IBA to assess electron beam, Rhodotron technology for PFAS destruction under PFAROS initiative

• IBA joined PFAROS, a European R&D initiative targeting PFAS destruction in pharmaceutical and medical applications.
• Co-leads end-of-life and waste-management work with Bayer; assesses electron beam and Rhodotron technology for PFAS destruction.
• Discovery Lab to test and benchmark PFAS removal from hospital and pharma wastewater, targeting long-, short-, ultrashort-chain PFAS.
• Program includes pre-concentration, polishing, advanced destruction steps to support mineralization and control by-products.
• Solid-waste work to evaluate thermal and non-thermal options, including electron beam and plasma, to guide scalable integrated treatment trains.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBA - Ion Beam Applications SA published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein.